Biotech Values

[DewDiligence]

JNJ—FDA approves generic versions of Tracleer:

#FDA approved several first generics for a drug used to treat pulmonary arterial hypertension, which is a rare, progressive disorder characterized by high blood pressure in the arteries of the lungs. This drug is managed by a REMS. https://t.co/5VuPkSm4jW pic.twitter.com/mxhe7l6kQp

— Media Affairs (@FDAMedia) April 29, 2019